Adam Hill, CEO, Oncimmune Holdings 00:00:00

Share On Facebook Share On Twitter

Oncimmune Holdings PLC's (LON:ONC) Adam Hill tells Proactive London about their master service agreement with California-based immunotherapy specialist Augmenta Bioworks.

Recent Videos